Tirzepatide is a synthetic peptide that acts as a dual agonist for GLP-1 and GIP receptors. It is widely used to improve glycemic control in type 2 diabetes and to promote significant weight loss in adults with obesity. It is administered once a week via subcutaneous injection. [1, 2, 3, 4, 5, 6]
How It Works
Tirzepatide mimics two natural incretin hormones: [1, 2, 3]
GLP-1 (Glucagon-like peptide-1): Slows stomach emptying to promote fullness and suppresses appetite in the brain.
GIP (Glucose-dependent insulinotropic polypeptide): Stimulates insulin release when blood sugar is high and may also reduce food intake. [1, 2]
Approved Medications
Tirzepatide is the active ingredient in two FDA-approved, prescription medications: [1, 2, 3, 4, 5]
Mounjaro: Approved for the management of type 2 diabetes.
Zepbound: Approved for chronic weight management in adults with obesity or those who are overweight with a weight-related condition. [1, 2, 3, 4]
Common Side Effects
The most frequent side effects are gastrointestinal in nature: [1, 2, 3, 4]
Nausea
Vomiting
Diarrhea or constipation
Stomach pain
Tirzepatide 30mg GLP1
Important Notices:
You Must be a researcher and over 18 years old to purchase.
· This product is sold for scientific research purposes only.
· Product is provided as a lyophilized (freeze-dried) powder in a sealed, sterile vial.
· The quantity on the label refers to the total amount of product inside each vial.
· Additional lab supplies are required for conducting research such as bacteriostatic water for reconstitution, syringes & needles to draw from the vials, and alcohol prep pads for sanitizing vial stoppers prior to needle insertion.
· Vial appearance, label, seal and cap colors may vary from product photos.
